Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

22.84
Delayed Data
As of Jul 31
 +1.16 / +5.35%
Today’s Change
16.57
Today|||52-Week Range
29.83
+4.96%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close21.68
Today’s open21.81
Day’s range21.63 - 23.89
Volume292,076
Average volume (3 months)131,337
Market cap$685.6M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+12.44%
Earnings growth (this year)+44.85%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.71%
P/E ratioNM
Price/Sales16.32
Price/Book8.93

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.51+3.24%
KPTIKaryopharm Therapeut...+0.44+2.19%
COCPCocrystal Pharma Inc-0.01-1.10%
RVNCRevance Therapeutics...-0.83-2.61%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$39.6M
Annual profit (last year)-$50.0M
Net profit margin-126.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts